306 related articles for article (PubMed ID: 14510988)
1. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
Hartmann K; Hermes B; Rappersberger K; Sepp N; Mekori YA; Henz BM
Br J Dermatol; 2003 Sep; 149(3):554-9. PubMed ID: 14510988
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.
Haas N; Hamann K; Grabbe J; Algermissen B; Czarnetzki BM
Arch Dermatol Res; 1995; 287(3-4):242-8. PubMed ID: 7541189
[TBL] [Abstract][Full Text] [Related]
3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
4. Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis.
Baldus SE; Zirbes TK; Thiele J; Eming SA; Henz BM; Hartmann K
Haematologica; 2004 Dec; 89(12):1525-7. PubMed ID: 15590405
[TBL] [Abstract][Full Text] [Related]
5. Pediatric mastocytosis.
Hartmann K; Metcalfe DD
Hematol Oncol Clin North Am; 2000 Jun; 14(3):625-40. PubMed ID: 10909043
[TBL] [Abstract][Full Text] [Related]
6. Mastocytosis and the skin.
Soter NA
Hematol Oncol Clin North Am; 2000 Jun; 14(3):537-55, vi. PubMed ID: 10909039
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
[TBL] [Abstract][Full Text] [Related]
9. Mastocytosis in infants and children: recognition of patterns of skin disease.
Kirshenbaum AS; Kettelhut BV; Metcalfe DD; Garriga MM
Allergy Proc; 1989; 10(1):17-21. PubMed ID: 2925086
[TBL] [Abstract][Full Text] [Related]
10. Expression of stem cell factor in cutaneous mastocytosis.
Hamann K; Haas N; Grabbe J; Czarnetzki BM
Br J Dermatol; 1995 Aug; 133(2):203-8. PubMed ID: 7547385
[TBL] [Abstract][Full Text] [Related]
11. Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes.
Hamann K; Haas N; Grabbe J; Welker P; Czarnetzki BM
Br J Dermatol; 1995 Oct; 133(4):547-52. PubMed ID: 7577581
[TBL] [Abstract][Full Text] [Related]
12. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
[TBL] [Abstract][Full Text] [Related]
13. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
14. [Morphology of mastocytosis].
Persina IS; Kasimov N
Arkh Patol; 1987; 49(7):26-32. PubMed ID: 3662856
[TBL] [Abstract][Full Text] [Related]
15. A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations.
Drabent P; Mitri R; Le Naour G; Hermine O; Rossignol J; Molina TJ; Barete S; Fraitag S
Am J Dermatopathol; 2021 Jan; 43(1):35-41. PubMed ID: 32568831
[TBL] [Abstract][Full Text] [Related]
16. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
[TBL] [Abstract][Full Text] [Related]
17. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
18. Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):5-14. PubMed ID: 26546030
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of reactive and neoplastic human tissue mast cells. An immunohistochemical study using the antibody PC10 (anti-PCNA).
Horny HP; Schumacher U; McCullagh P; Wehrmann M; Roche WR; Kaiserling E
J Pathol; 1993 Jul; 170(3):265-70. PubMed ID: 7907655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
